- Published at
- by gurufocus.com
positive
positive
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods | IPA Stock News
ImmunoPrecise Antibodies (NASDAQ: IPA) backs FDA's move away from animal testing. Company's AI platform LENSaiâ„¢ aligns with FDA's New Approach Methodo